CONTENTS:
- The problem with good news: how should public health actors respond when alcohol consumption declines? [Editorial]. Whitaker V., Oldham M., Angus C., Fairbrother H., Holmes J., p. 1987-1988.
- Associations between solitary drinking and increased alcohol consumption, alcohol problems, and drinking to cope motives in adolescents and young adults: a systematic review and meta-analysis. Skrzynski C.J., Creswell K.G., p. 1989-2007.
- Behaviour change techniques associated with smoking cessation in intervention and comparator groups of randomized controlled trials: a systematic review and meta-regression. Black N., Johnston M., Michie S., Hartmann-Boyce J., West R., Viechtbauer W., et al., p. 2008-2020.
- Evaluating the causal impact of individual alcohol licensing decisions on local health and crime using natural experiments with synthetic controls. de Vocht F., McQuire C., Brennan A., Egan M., Angus C., Kaner E., et al., p. 2021-2031.
- Commentary on de Vocht et al. (2020): The value of local causal inference models for alcohol policy debates. Trangenstein P.J., p. 2032-2033.
- Acute alcohol withdrawal and recovery in men lead to profound changes in DNA methylation profiles: a longitudinal clinical study. Witt S.H., Frank J., Frischknecht U., Treutlein J., Streit F., Foo J.C., et al., p. 2034-2044.
- Incidence of assault in Sydney, Australia, throughout 5 years of alcohol trading hour restrictions: controlled before-and-after study. Kypri K., Livingston M., p. 2045-2054.
- Commentary on Kypri & Livingston (2020): Alcohol trading hour restrictions reduce assault incidence. Foulds J.A., p. 2055-2056.
- Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Sufrin C., Sutherland L., Beal L., Terplan M., Latkin C., Clarke J.G., p. 2057-2065.
- A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales. Gibson R., MacLeod N., Donaldson L.J., Williams H., Hibbert P., Parry G., et al., p. 2066-2076.
- Commentary on Gibson et al. (2020): Medications for opioid use disorder- access, retention, and safety. Timko C., Hoggatt K., p. 2077-2078.
- A life-course theory exploration of opioid-related maternal mortality in the United States. Cleveland L.M., McGlothen-Bell K., Scott L.A., Recto P., p. 2079-2088.
- Trends in marijuana use in two Latin American countries: an age, period and cohort study. Castillo-Carniglia A., Rivera-Aguirre A., Calvo E., Queirolo R., Keyes K.M., Cerda M., p. 2089-2097.
- Factors associated with receipt of the 5As model of brief intervention for smoking cessation among hospitalized patients. Martinez C., Feliu A., Castellano Y., Fu M., Fernandez P., Cabrera-Jaime S., et al., p. 2098-2112.
- Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study. Li J., Fairhurst C., Peckham E., Bailey D., Arundel C., Hewitt C., et al., p. 2113-2122.
- Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non-daily smokers: a secondary analysis. Shiffman S., Ferguson S.G., Mao J., Scholl S.M., Hedeker D., Tindle H.A., p. 2123-2129.
- Personality traits in substance use disorders and obesity when compared to healthy controls. Ramirez V., Wiers C.E., Wang G.J., Volkow N.D., p. 2130-2139.
- The association between parental supply of alcohol and supply from other sources to young people: a prospective cohort. Boland V.C., Clare P.J., Yuen W.S., Peacock A., Aiken A., Wadolowski M., et al., p. 2140-2147.
- Alcohol use in pregnancy and its impact on the mother and child. Oei J.L., p. 2148-2163.
- Predicting alcohol dependence treatment outcomes: a prospective comparative study of clinical psychologists versus 'trained' machine learning models. Symons M., Feeney G.F.X., Gallagher M.R., Young R.M., Connor J.P., p. 2164-2175.
- A re-analysis of e-cigarette use and heart attacks in PATH wave 1 data. Rodu B., Plurphanswat N., p. 2176-2179.
- The proper approach to assessing the impact of the fact that e-cigarettes were not available before 2007. Bhatta D.N., Glantz S.A., p. 2180-2182.
- Restoring the Bacloville trial: efficacy and harms. Naudet F., Braillon A., Cristea I.A., Lexchin J., p. 2184-2186.
- Reply to comments on the Rigal et al. (2019) Bacloville trial. Rigal L., Sidorkiewicz S., Le Jeunne C., Porcher R., Jaury P., p. 2186-2187.
- Extinction as the behavioral mechanism of the naltrexone-extended release for opioid dependence: could there be an alternative explanation? Ghosh A., Singh P., p. 2187-2188.
- Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Nunes E.V., Bisaga A., Krupitsky E., Nangia N., Silverman B.L., Akerman S.C., et al., p. 2188-2190.